Bone Health

It is estimated that 3 million people in the UK suffer from osteoporosis, costing the NHS more than £4.4 million.

Figures suggest the annual incidence of hip fractures in the UK will rise from 91,500 recorded in 2015 to 101,000 by the end 2020.

Using your practice clinical system and our bespoke searches, Interface can:

• Identify patients not receiving optimal treatment as per national guidance
• Prioritise those patients managed outside of the practice-specified management framework
• Collate patients with a high risk of fragility fracture who are currently not being treated

Our Clinical Pharmacists can also support with QOF disease register maintenance ensuring appropriate patients are coded correctly and practices are rewarded for their care.

High-priority patients will be flagged for practice review and will be provided with educational materials to help understand their fracture risk and treatment supporting concordance.

Practices will be provided with a summary report to demonstrate Quality Improvement in the management of patients with osteoporosis or high fragility fracture risk to support future workstreams and PDSA cycles.